Donald P Tashkin (Donald Tashkin)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 16

Top Topics

Chronic Obstructive Pulmonary Disease

Heart Rate Variability

Smoking Cessation

Systemic Sclerosis

Top Venues

Journal of scleroderma and related disorders

American journal of respiratory and critical care medicine

Journal of aerosol medicine and pulmonary drug delivery

Annals of the American Thoracic Society

This page only lists publications with an associated author ORCID identifier.

Publications

Donald P Tashkin, Igor Barjaktarevic, Julio Gomez-Seco, Naser Hassan Behbehani, Arkady Koltun, Urooj Alam Siddiqui
Prevalence and Management of Chronic Obstructive Pulmonary Disease in the Gulf Countries with a Focus on Inhaled Pharmacotherapy. Journal of aerosol medicine and pulmonary drug delivery (2024)
Donald P Tashkin, Igor Barjaktarevic, Julio Gomez-Seco, Naser Hassan Behbehani, Arkady Koltun, Urooj Alam Siddiqui
Prevalence and Management of Chronic Obstructive Pulmonary Disease in the Gulf Countries with a Focus on Inhaled Pharmacotherapy. Journal of aerosol medicine and pulmonary drug delivery 37 (4) (2024)
Elizabeth R Volkmann, Donald P Tashkin
Outcomes of systemic sclerosis associated interstitial lung disease patients with a persistent inflammatory phenotype based on serial CRP measurements. Thorax (2023)
Russell G Buhr, Igor Z Barjaktarevic, P Miguel Quibrera, Lori A Bateman, Eugene R Bleecker, David J Couper, Jeffrey L Curtis, Brett A Dolezal, Meilan K Han, Nadia N Hansel, Jerry A Krishnan, Fernando J Martinez, William McKleroy, Robert Paine, Stephen I Rennard, Donald P Tashkin, Prescott G Woodruff, Richard E Kanner, Christopher B Cooper, null null
Reversible Airflow Obstruction Predicts Future Chronic Obstructive Pulmonary Disease Development in the SPIROMICS Cohort: An Observational Cohort Study. American journal of respiratory and critical care medicine 206 (5) (2022)
David Roofeh, Kevin K Brown, Ella Annabelle Kazerooni, Donald P Tashkin, Shervin Assassi, Fernando J Martinez, Athol U Wells, Ganesh Raghu, Christopher P Denton, Lorinda S Chung, Anna-Maria Hoffmann-Vold, Oliver Distler, Kerri A Johannson, Yannick Allanore, Eric L Matteson, Leticia Kawano-Dourado, John D Pauling, James R Seibold, Elizabeth R Volkmann, Simon L F Walsh, Chester V Oddis, Eric S White, Shaney Louise Barratt, Elana J Bernstein, Robyn T Domsic, Paul F Dellaripa, Richard Conway, Ivan O Rosas, Nitin Bhatt, Vivien Hsu, Francesca Ingegnoli, Bashar Kahaleh, Puneet S Garcha, Nishant Gupta, Surabhi Khanna, Peter Korsten, Celia Lin, Stephen C Mathai, Vibeke Strand, Tracy J Doyle, Virginia Steen, Donald F Zoz, Juan Gabriel Ovalles, Ignasi Rodríguez-Pintó, Padmanabha D Shenoy, Andrew Lewandoski, Elizabeth Belloli, Alain Lescoat, Vivek Nagaraja, Wen Ye, Suiyuan Huang, Toby M Maher, Dinesh Khanna
Systemic Sclerosis Associated Interstitial Lung Disease: A Conceptual Framework for Subclinical, Clinical, and Progressive Disease. Rheumatology (Oxford, England) (2022)
Seon-Cheol Park, Narongkorn Saiphoklang, Donghyun Jung, David Gomez, Jonathan E Phillips, Brett A Dolezal, Donald P Tashkin, Igor Z Barjaktarevic, Christopher B Cooper
Use of a Wearable Biosensor to Study Heart Rate Variability in Chronic Obstructive Pulmonary Disease and Its Relationship to Disease Severity. Sensors (Basel, Switzerland) 22 (6) (2022)
Donald P Tashkin, Jill A Ohar, Arkady Koltun, Richard Allan, Jonathan K Ward
The Role of ICS/LABA Fixed-Dose Combinations in the Treatment of Asthma and COPD: Bioequivalence of a Generic Fluticasone Propionate-Salmeterol Device. Pulmonary medicine 2021 (2021)
Sangmee Sharon Bae, Lila Pourzand, Grace Hyun Kim, Bianca E Villegas, Andrea Oh, Daniel E Furst, Jonathan Goldin, Donald P Tashkin
The disconnect between visual assessment of air trapping and lung physiology for assessment of small airway disease in scleroderma-related interstitial lung disease: An observation from the Scleroderma Lung Study II Cohort. Journal of scleroderma and related disorders 7 (2) (2021)
Donald P Tashkin, Xiaoli Niu, Sanjay Sharma, Shahin Sanjar
Impact of baseline clinical features on outcomes of nebulized glycopyrrolate therapy in COPD. NPJ primary care respiratory medicine 31 (1) (2021)
Donald P Tashkin
Smoking cessation in COPD: confronting the challenge. Internal and emergency medicine 16 (3) (2021)
Zsuzsanna H McMahan, Donald P Tashkin, Athol U Wells, James R Seibold, Stephen Wax, Cristina Vazquez-Mateo, Patricia Fleuranceau-Morel, Doris Damian, Christopher P Denton
STRATUS: A Phase II Study of Abituzumab in Patients With Systemic Sclerosis-associated Interstitial Lung Disease. The Journal of rheumatology 48 (8) (2020)
Donald P Tashkin, Brian Lipworth, Ralph Brattsand
Benefit:Risk Profile of Budesonide in Obstructive Airways Disease. Drugs 79 (16) (2020)
Donald P Tashkin
Vaping Cannabis and Chronic Obstructive Pulmonary Disease. Annals of the American Thoracic Society 15 (10) (2019)
Donald P Tashkin, Michael D Roth
Pulmonary effects of inhaled cannabis smoke. The American journal of drug and alcohol abuse 45 (6) (2019)
Donald P Tashkin
To Withdraw or Not to Withdraw Inhaled Corticosteroids from Triple Therapy in Chronic Obstructive Pulmonary Disease. American journal of respiratory and critical care medicine 198 (3) (2019)
Elizabeth R Volkmann, Donald P Tashkin, Myung Sim, Grace Hyun Kim, Jonathan Goldin, Philip J Clements
Determining progression of scleroderma-related interstitial lung disease. Journal of scleroderma and related disorders 4 (1) (2018)